The cost of diabetic macular oedema in the Australian workforce

cost of diabetic macular oedema

This year alone diabetic macular oedema (DME) is estimated to be responsible for $2.07 billion in indirect economic costs in Australia, with a significant portion of this to be due to a reduced capacity at work and lost wellbeing as a result of impaired vision. According to a report by Deloitte Access Economics which was [Read More…]